The Ghana Association of Medical Herbalists (GAMH) said it is still working behind the scenes to produce a herbal drug that will help fight COVID-19.
The Association’s Secretary General, Dr Prince Osei, explained that since the start of the pandemic, the Association has been monitoring the situation closely to bring out the best herbal medicines that will allow the disease to be managed. However, the support was not optimal.
Speaking to Samuel Eshun on the Happy Morning Show, he said, “Now that we have these vaccines available, we believe clinical trials should continue.
Our original plan was to partner with the Ministry of Health to administer approved herbal medicines to people held in isolation centers if they so choose. Then we can administer and monitor to see how the person’s response is. This is how we can collect data and compare it to the effectiveness of orthodox medicine. This is what we were proposing, unfortunately we pushed this program forward and yet we did not get any favorable response.
Despite the apparent setback in the production of a herbal medicine for COVID-19, Dr Prince Osei is confident that the Association will come up with herbal medicine as he said: “It is a fact that many haven’t heard from us but we are still working on herbal medicines.
In February 2021, the Food and Drugs Authority (FDA) approved the first herbal drug for clinical trials for the treatment of COVID-19.
According to a press release issued by the FDA, the authority in conjunction with the National Medicine Regulatory Agency (NMRA) has approved a clinical trial of “Cryptolepis Sanguinolenta”, known locally as “Nibima” for its efficacy in treating of Covid-19 cases.
The application for a clinical trial of said herbal medicine was submitted by researchers at the School of Public Health at Kwame Nkrumah University of Science and Technology (KNUST).